OOpportunity Health
Opportunity Health is a Spanish medtech startup developing YARNASA, the first automatic, self-applicable anti-choking device — a CO2-cartridge-powered unit that uses the Venturi effect to clear an obstructed airway in seconds without third-party help or medical training. Founded in 2024 in Sangüesa (Navarra) and targeting B2B buyers such as care homes, hospitals, restaurants, schools and public transport, it is at seed stage, having raised ~€334,000 (Easo Ventures, Sodena, an ENISA participative loan and a Startupxplore crowd round closed in January 2026). It won the Start-up Pitch Contest at BioSpain 2025 and is working toward Class IIa CE marking, expected around 2027.
SectorsHealthtech & Bio, Medical Devices, Emergency Medicine, Deeptech & Hardware
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
G
Germán Alejandro Sánchez Martín
Founder & CEO
Global models 2
AAvive Solutions
United States · avive.life ↗
Sells a compact, easy-to-use emergency rescue device (an AED) to schools, workplaces and public venues so untrained bystanders can act in seconds, the same buyers and model as YARNASA.
$60MComparable
HHeartHero
United States · www.hearthero.com ↗
Makes a small, simple AED sold to institutions and consumers so anyone can use it without medical training, following the same model as an automatic anti-choking device.
$10MComparable
In the same niche 72 others
See all in the Start-ups Map →
AAnaconda Biomed
Sant Cugat del Vallès
Series C (estimated) · €90.1M
IINBRAIN Neuroelectronics
Barcelona
Series B (estimated) · €84.5M
OOverture Life
Madrid
Venture Debt · €71.2M
M
Medlumics
Madrid
No stage disclosed · €57.8M
AAortyx
Barcelona
Series A · €16.9M
NNuubo
Madrid
Series B (estimated) · €16.3M
Notes: Most funded first
Investors 3
Open as list →
Funding rounds 2
·1 not counted| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-01-28 | Pre-seed (estimated) | €334K incl. debt: equity and debt, the split was not disclosed |
Lead not disclosed
+3 more
|
| 2025-04-09 | Pre-seed | €100K |
Lead not disclosed
+2 more
|
News
No coverage on record yet.